WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'1301 Infant (under 12 months) mortality rate: 492
GDP / capita (US$): 3'3721 Child (under 5 years) mortality rate: 732

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 38'764  37'964  37'195  36'431  35'652  27'730  20'009  14'418 
Births 1'287  1'275  1'263  1'252  1'241  1'110  850  653 
Surviving infants 1'218  1'206  1'193  1'182  1'170  1'032  780  596 
Pop. less than 5 years 5'781  5'722  5'671  5'625  5'583  4'733  3'505  2'729 
Pop. less than 15 years 15'836  15'635  15'432  15'219  14'992  12'125  9'096  6'771 
Female 15-49 years 9'415  9'181  8'959  8'741  8'521  6'473  4'500  3'124 

Number of reported case

(Click for retrospective incidence data for Sudan (the))
Diphtheria 11  18  193  26  1'342  587 
Japanese encephalitis
Measles 676  2'813  8'523  5'616  680  2'875  14'075  50'168 
Mumps
Pertussis 141  119  109  132  209  80  566  28'631 
Polio* 79  4'151 
Rubella 817  291  191  237  345 
Rubella (CRS)
Tetanus (neonatal) 133  88  128  168  260  88  28  90 
Tetanus (total)** 139  88  137  174  273  411  4'451 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sudan (the))
Vaccine year result method % card seen                                                
BCG 2009  77  MICS   41  95  93  92  92  91  66  73 
DTP1 2009  79  MICS   41  99*  99*  99*  99*  99*  70 
DTP3 2009  61  MICS   41  94  93  92  93  95  65  62 
HepB_BD         
HepB3 2009  61  MICS   41  94  93  92  93  95 
Hib3 2009  61  MICS   41  94  93  92  93  95 
JapEnc         
MCV          86  85  85  87  86  60  57 
MCV2          61  57  24 
PCV1          99*  70 
PCV3          97  30 
Pol3 2009  65  MICS   41  94  93  92  93  95  65  62 
Rota1          90  86  81  92 
Rota_last          86  80  75  64 
Rubella1         
TT2plus 1992  16  PAPCHILD     53  50  47  47  45  34  75 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sudan (the))
BCG 93  92  92  90  56  77 
DTP1 99  99  99  99  75  83  18 
DTP3 93  92  93  90  62  62 
HepB3 93  92  93  75 
HepB_BD
Hib3 93  92  93  75 
MCV 85  85  87  90  58  57 
MCV2 57  24 
PAB 74  74  74  74  61  72 
PCV3 30 
Pol3 93  92  93  90  62  62 
Rota_last 80  75  27 
YFV

Number of districts in the country 174  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 74
From 80 to 89% 16
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
3
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From May 2015
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 month; +1, +1 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2011-2015  2011-2015  2010-2014  2010-2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 169  168  162  160  157  141  133 

System performance

Total Nº districts in country number 174  168  162  160  157  143  135 
Nº districts with DTP3 coverage >=80% number 157  156  133  144  139  116  116 
% of districts with DTP3 coverage >=80% From 0 to 100% 90  93  82  90  89  81  86 
Nº districts with measles (MCV1) coverage >=95% number 54  36  33  38  41  26  19 
% of districts with MCV1 coverage >=95% From 0 to 100% 31  21  20  24  26  18  14 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 12  12  55  19 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.